• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰胆碱治疗局部脂肪堆积

Phosphatidylcholine in the treatment of localized fat.

作者信息

Hexsel Doris, Serra Marcio, Mazzuco Rosemari, Dal'Forno Taciana, Zechmeister Debora

机构信息

Doris Hexsel Dermatologic Clinic, Porto Alegre, Brazil.

出版信息

J Drugs Dermatol. 2003 Oct;2(5):511-8.

PMID:14558399
Abstract

Phosphatidylcholine was initially used in emergencies and in the treatment of atheroma plaques in cardiac diseases. Recently, it has also been used in the treatment of localized fat deposits. We report on the authors' clinical experience of the use of 250 mg/ml phosphatidylcholine injections in the treatment of subcutaneous fat deposits, showing the clinical response and side-effects. Volunteers received phosphatidylcholine injections in several areas of localized fat deposits, with a minimum interval of one week and mean interval of 15 days between applications. Laboratory tests were performed during the period of the drug use. Clinical results reflect that phosphatidylcholine was efficacious in reducing the fatty pads in the treated areas, with few side effects. From the authors' point of view, the off-label use of phosphatidylcholine in the treatment of fatty pads and small areas of localized fat is safe, low cost, and effective.

摘要

磷脂酰胆碱最初用于紧急情况以及心脏病中动脉粥样斑块的治疗。最近,它也被用于治疗局部脂肪堆积。我们报告了作者使用250毫克/毫升磷脂酰胆碱注射液治疗皮下脂肪堆积的临床经验,展示了临床反应和副作用。志愿者在几个局部脂肪堆积区域接受了磷脂酰胆碱注射,每次注射间隔至少一周,平均间隔为15天。在用药期间进行了实验室检查。临床结果表明,磷脂酰胆碱在减少治疗区域的脂肪垫方面有效,且副作用较少。从作者的角度来看,磷脂酰胆碱在治疗脂肪垫和小面积局部脂肪方面的超说明书用药是安全、低成本且有效的。

相似文献

1
Phosphatidylcholine in the treatment of localized fat.磷脂酰胆碱治疗局部脂肪堆积
J Drugs Dermatol. 2003 Oct;2(5):511-8.
2
Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study.
J Cosmet Dermatol. 2007 Dec;6(4):250-7. doi: 10.1111/j.1473-2165.2007.00343.x.
3
Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads.使用磷脂酰胆碱矫正因眶隔脂肪突出导致的下睑膨隆。
J Cosmet Laser Ther. 2006 Sep;8(3):129-32. doi: 10.1080/14764170600891756.
4
Mesotherapy and phosphatidylcholine injections: historical clarification and review.中胚层疗法与磷脂酰胆碱注射:历史阐释与综述
Dermatol Surg. 2006 Apr;32(4):465-80. doi: 10.1111/j.1524-4725.2006.32100.x.
5
The use of phosphatidylcholine for correction of localized fat deposits.使用磷脂酰胆碱纠正局部脂肪堆积。
Aesthetic Plast Surg. 2003 Jul-Aug;27(4):315-8. doi: 10.1007/s00266-003-3033-y.
6
Injection lipolysis for reduction of saddlebag trochanteric bulges--half-side controlled pilot study.注射溶脂术减少臀外侧转子区赘肉——半侧对照性初步研究
J Dtsch Dermatol Ges. 2008 Apr;6(4):287-90. doi: 10.1111/j.1610-0387.2007.06571.x. Epub 2007 Dec 13.
7
Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat.皮下注射脱氧胆酸盐与磷脂酰胆碱 - 脱氧胆酸盐组合用于减少颏下脂肪的随机双盲临床试验。
Dermatol Surg. 2009 May;35(5):792-803. doi: 10.1111/j.1524-4725.2009.01130.x. Epub 2009 Apr 6.
8
Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study.脂肪瘤脂肪分解后的脂肪组织:一项组织病理学和免疫组织化学研究。
J Cutan Pathol. 2007 Jul;34(7):552-7. doi: 10.1111/j.1600-0560.2006.00651.x.
9
Fat reduction using phosphatidylcholine/sodium deoxycholate injections: standard of practice.使用磷脂酰胆碱/脱氧胆酸钠注射进行减脂:实践标准。
Aesthetic Plast Surg. 2008 Nov;32(6):858-72. doi: 10.1007/s00266-008-9188-9. Epub 2008 Jul 9.
10
Histological changes associated with mesotherapy for fat dissolution.与溶脂中胚层疗法相关的组织学变化。
J Cosmet Laser Ther. 2005 Mar;7(1):17-9. doi: 10.1080/14764170510037743.

引用本文的文献

1
Non-invasive caffeinated-nanovesicles as adipocytes-targeted therapy for cellulite and localized fats.非侵入性含咖啡因纳米囊泡作为治疗橘皮组织和局部脂肪的脂肪细胞靶向疗法。
Int J Pharm X. 2024 Mar 13;7:100236. doi: 10.1016/j.ijpx.2024.100236. eCollection 2024 Jun.
2
Injection Lipolysis: A Systematic Review of Literature and Our Experience with a Combination of Phosphatidylcholine and Deoxycholate over a Period of 14 Years in 1269 Patients of Indian and South East Asian Origin.注射溶脂术:文献系统综述及我们在14年中对1269名印度和东南亚裔患者使用磷脂酰胆碱和脱氧胆酸盐组合的经验
J Cutan Aesthet Surg. 2018 Oct-Dec;11(4):222-228. doi: 10.4103/JCAS.JCAS_117_18.
3
Selective effect of phosphatidylcholine on the lysis of adipocytes.
磷脂酰胆碱对脂肪细胞溶解的选择性作用。
PLoS One. 2017 May 2;12(5):e0176722. doi: 10.1371/journal.pone.0176722. eCollection 2017.
4
Injection therapy for the management of superficial subcutaneous lipomas.用于浅表皮下脂肪瘤治疗的注射疗法
J Clin Aesthet Dermatol. 2014 Jun;7(6):46-8.
5
Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.对两项欧洲的、随机的、安慰剂对照的3期研究进行汇总分析的结果,这些研究是关于ATX-101用于药物性减少颏下多余脂肪的。
Aesthetic Plast Surg. 2014 Oct;38(5):849-60. doi: 10.1007/s00266-014-0364-9. Epub 2014 Jul 2.
6
Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.体外冲击波治疗脂肪团的个体临床疗效的可预测性。
Clin Cosmet Investig Dermatol. 2014 May 23;7:171-83. doi: 10.2147/CCID.S59851. eCollection 2014.
7
Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial.磷脂酰胆碱和脱氧胆酸钠注射对皮下脂肪的代谢和结构影响:一项随机对照试验。
Aesthet Surg J. 2013 Mar;33(3):400-8. doi: 10.1177/1090820X13478630. Epub 2013 Feb 25.
8
The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: an experimental study with a murine model.磷脂酰胆碱和脱氧胆酸盐复合注射对局部脂肪组织的影响:一项小鼠模型的实验研究。
Arch Plast Surg. 2012 Sep;39(5):452-6. doi: 10.5999/aps.2012.39.5.452. Epub 2012 Sep 12.
9
[Injection lipolysis].
Hautarzt. 2010 Oct;61(10):847-55. doi: 10.1007/s00105-010-1984-x.
10
Compounds used for 'injection lipolysis' destroy adipocytes and other cells found in adipose tissue.用于“注射式脂肪分解”的化合物会破坏脂肪组织中的脂肪细胞和其他细胞。
Obes Facts. 2009;2(1):36-9. doi: 10.1159/000193461. Epub 2009 Feb 3.